Boardroom Alpha
Boardroom Alpha
STAA · Additional Proxy Materials (DEFA14A) · Filed May 4, 2026

Staar Surgical Co — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 4, 2026
Ticker
STAA
Accession
0000718937-26-000016
Boardroom Alpha · Filing insights

STAAR Surgical board urges voting For all proposals at the 2026 annual meeting: director slate, equity plan amendment, say-on-pay, and auditor ratification.

About Staar Surgical Co
Market cap
$1.4B
1Y TSR
+74.5%
3Y TSR
−17.2%
Board grade
C
Sector
Healthcare
CEO
Deborah J Andrews
Last annual meeting: Jun 18, 2026 · View full Staar Surgical Co profile →
DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

 

Filed by the Registrant

 

 

 

 

 

Filed by a Party other than the Registrant

 

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under §240.14a-12

 

STAAR Surgical Company

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0‑11.

 


 

 

img217286323_0.jpg

STAAR SURGICAL COMPANY 25510 COMMERCENTRE DRIVE LAKE FOREST, CA 92630 ATTN: CORPORATE SECRETARY Your Vote Counts! STAAR SURGICAL COMPANY 2026 Annual Meeting Vote by June 17, 2026 11:59 PM ET V91896-P51167 You invested in STAAR SURGICAL COMPANY and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on June 18, 2026. Get informed before you vote View the Form 10-K and Notice and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 4, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote Virtually at the Meeting* June 18, 2026 8:30 AM PDT Virtually at: www.virtualshareholdermeeting.com/STAA2026 *Please check the meeting materials for any special requirements for meeting attendance

 


 

 

img217286323_1.jpg

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Voting Items 1. Election of Directors For Nominees: 01) Neal C. Bradsher 02) Arthur C. Butcher 03) Wei Jiang 04) Richard T. LeBuhn 05) Louis E. Silverman 06) Christopher M. Wang 07) Lilian Y. Zhou 2. Approve an amendment to the Company’s Amended and Restated Omnibus Equity Incentive Plan, as amended 3. Ratify the appointment of the Company’s independent registered public accounting firm for fiscal 2026. 4. Approve on a non-binding advisory basis the compensation of the Company’s named executive officers (“say-on-pay”). NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting of Shareholders or any postponement or adjournment thereof. Board Recommends For For For For Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

 


From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Staar Surgical Co (STAA)

Reference

Frequently asked questions

When did Staar Surgical Co file this DEFA14A?
Staar Surgical Co (STAA) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 4, 2026. The accession number assigned by EDGAR is 0000718937-26-000016.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
STAAR Surgical board urges voting For all proposals at the 2026 annual meeting: director slate, equity plan amendment, say-on-pay, and auditor ratification. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Staar Surgical Co's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Staar Surgical Co has filed under CIK 718937, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer